MB "Fibroblastai" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 13,600 |
| 10,968 |
| 1,781 |
| 1,689 |
| 1,362 |
| 100.00 |
| 12.42 |
| 4,777 |
| 835 |
| 6,252 |
| 5,612 |
| 2023 |
|---|
| 22,350 |
| 11,175 |
| 1,428 |
| 1,356 |
| 678 |
| 99.93 |
| 6.07 |
| 6,133 |
| 598 |
| 3,254 |
| 6,731 |
| 2024 |
|---|
| 29,600 |
| 14,369 |
| 12,135 |
| 11,527 |
| 5,596 |
| 99.79 |
| 38.94 |
| 17,660 |
| 2,237 |
| 255 |
| 19,897 |
Register and
explore Okredo data| 2024 |
|---|
| 29,600 |
| 14,369 |
| 12,135 |
| 11,527 |
| 5,596 |
| 99.79 |
| 38.94 |
| 17,660 |
| 2,237 |
| 255 |
| 19,897 |
Register and
explore Okredo data2024
Turnover (€)
29,600 €
32 % *
Sales per employee (€)
14,369 €29 % *
Profit before tax (€)
12,135 €750 % *
Net Profit (€)
11,527 €750 % *
Profit per employee (€)
5,596 €725 % *
Total profitability (%)
99.79 %
-0.14 % *
Net profitability (%)
38.94 %541.52 % *
Equity (€)
17,660 €188 % *
Amounts Payable And Liabilities (€)
2,237 €
274 % *
Non-current Assets (€)
255 €
-92 % *
CurrentAssets (€)
19,897 €196 % *